ICON Public Limited Company (ICLR)

NasdaqGS Currently up 1.27 (+0.78%) in today's trading session

3 members of Congress have disclosed 13 trades in ICON Public Limited Company (ICLR) via STOCK Act filings. The most recent disclosure was a sale by Kevin Hern on 14 August 2026. The most active traders have been Kevin Hern (10), John James (2), and Julia Letlow (1). Aggregate disclosed activity totals roughly $322.5K in purchases and $231.5K in sales (midpoint estimates from bracketed disclosure amounts).

ICON Public Limited Company is currently trading at $164.85, positioned at 72% of its 52-week range ($66.57 – $203.91).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$164.85
24h Change
+1.27 (+0.78%)
52 Week Range
$66.57$203.91
View on NASDAQ

ICON Public Limited Company Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for ICLR

Select to highlight on chart
5 transactions
Compliance: 85%
Kevin Hern14 Aug 20261 Sept 2026SaleStock$15,001 - $50,000N/A
Kevin Hern5 Mar 20263 Apr 2026SaleStock$100,001 - $250,000N/A
Julia Letlow12 Feb 202612 Mar 2026SaleStock$1,001 - $15,000N/A
John James4 Sept 20246 Sept 2024SaleStock$1,001 - $15,000N/A
John James12 Jun 20242 Sept 2024PurchaseStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$12.62B

Volume

796.4K

Beta

1.20

P/E Ratio

13.45

Fundamentals

EPS

$12.26

Div. Yield

-

Open

$159.94

Day Range

$159.50 – $165.87

Company Information

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ · USD
Country
IE
CEO
Barry Balfe
IPO Date
1998-05-15

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, ma...

Earnings

Next Report

Q3 2026

28 Oct

EPS Est.

$2.69

Rev. Est.

$2B

Days Until

51

Recent Quarters

Q2 202629 Jul
EPS$2.56
Beat 0.4%
Q1 202623 Jun
EPS$2.50
Beat 1.6%
Q1 202627 May
EPS$2.52
Miss 19.5%
Q3 202522 Oct
EPS$3.31
Beat 0.9%
Q2 202523 Jul
EPS$3.26
Beat 2.2%
Q1 202530 Apr
EPS$3.19
Beat 2.6%
Q4 202419 Feb
EPS$3.43
Beat 0.6%
Q3 202423 Oct
EPS$3.35
Miss 12.8%
Q2 202424 Jul
EPS$3.75
Beat 1.9%
Q1 202424 Apr
EPS$3.47
Beat 1.8%
Q4 202321 Feb
EPS$3.46
Beat 0.6%
Q3 202326 Oct
EPS$3.30
Beat 0.6%
Q2 202327 Jul
EPS$3.11
Beat 1.0%
Q1 202327 Apr
EPS$2.90
Beat 0.7%
Q4 202223 Feb
EPS$3.13
Beat 2.6%
Q3 20222 Nov
EPS$3.00
Beat 2.0%
Q2 202227 Jul
EPS$2.86
Beat 2.5%
Q1 202227 Apr
EPS$2.76
Beat 2.2%
Q4 202122 Feb
EPS$2.63
Beat 0.4%
Q3 20213 Nov
EPS$2.55
Beat 5.4%
Q2 202121 Jul
EPS$2.12
Beat 1.4%
Q1 202128 Apr
EPS$2.06
Beat 4.6%
Q4 202024 Feb
EPS$1.90
Beat 3.8%
Q3 202021 Oct
EPS$1.72
Beat 12.4%
Q2 202022 Jul
EPS$1.20
Beat 9.1%
Q1 202022 Apr
EPS$1.70
Beat 1.2%
Q4 201919 Feb
EPS$1.83
Beat 0.0%
Q3 201923 Oct
EPS$1.74
Beat 0.0%
Q2 201924 Jul
EPS$1.69
Beat 0.6%
Q1 20191 May
EPS$1.63
Beat 1.9%
Q4 201820 Feb
EPS$1.62
Beat 1.3%
Q3 201824 Oct
EPS$1.54
Beat 0.0%
Q2 201825 Jul
EPS$1.51
Beat 2.0%
Q1 20182 May
EPS$1.42
Beat 0.0%
Q4 201715 Feb
EPS$1.43
Beat 0.7%
Q3 201726 Oct
EPS$1.35
Beat 2.3%
Q2 201727 Jul
EPS$1.31
Beat 0.8%
Q1 201727 Apr
EPS$1.29
Beat 1.6%
Q4 201616 Feb
EPS$1.26
Beat 0.0%
Q3 201620 Oct
EPS$1.19
Beat 0.8%
Q2 201626 Jul
EPS$1.14
Beat 0.0%
Q1 201626 Apr
EPS$1.12
Beat 0.9%
Q4 201523 Feb
EPS$1.11
Beat 0.9%
Q3 201527 Oct
EPS$1.02
Beat 1.0%
Q2 201528 Jul
EPS$0.95
Beat 6.7%
Q1 201528 Apr
EPS$0.86
Beat 4.9%
Q4 201425 Feb
EPS$0.87
Beat 14.5%
Q3 201422 Oct
EPS$0.79
Beat 12.9%
Q2 201430 Jul
EPS$0.64
Beat 10.3%
Q1 201430 Apr
EPS$0.57
Beat 14.0%
Q4 201320 Feb
EPS$0.53
Beat 17.8%
Q3 201324 Oct
EPS$0.45
Beat 9.8%
Q2 201325 Jul
EPS$0.43
Beat 13.2%
Q1 201325 Apr
EPS$0.36
Beat 5.9%
Q4 201219 Feb
EPS$0.34
Beat 3.0%
Q3 20121 Nov
EPS$0.29
Beat 7.4%
Q2 201224 Jul
EPS$0.21
Miss 4.5%
Q1 201224 Apr
EPS$0.15
Beat 0.0%
Q4 201116 Feb
EPS$0.07
Miss 22.2%
Q3 201127 Oct
EPS$0.02
Beat 100.0%
Q2 201120 Jul
EPS$0.21
Miss 4.5%
Q1 201121 Apr
EPS$0.21
Beat 0.0%
Q4 201024 Feb
EPS$0.36
Beat 0.0%
Q3 201021 Oct
EPS$0.33
Miss 10.8%
Q2 201027 Jul
EPS$0.38
Beat 2.7%
Q1 201027 Apr
EPS$0.37
Beat 0.0%
Q4 200925 Feb
EPS$0.40
Beat 5.3%
Q3 200921 Oct
EPS$0.40
Beat 17.6%
Q2 200922 Jul
EPS$0.38
Beat 11.8%
Q1 200928 Apr
EPS$0.35
Beat 2.9%
Q4 200823 Feb
EPS$0.35
Beat 2.9%
Q3 200821 Oct
EPS$0.35
Beat 9.4%
Q2 200822 Jul
EPS$0.31
Beat 6.9%
Q1 200829 Apr
EPS$0.28
Beat 3.7%
Q4 200721 Feb
EPS$0.27
Beat 8.0%
Q3 200723 Oct
EPS$0.25
Beat 8.7%
Q2 200726 Jul
EPS$0.23
Beat 4.5%
Q1 200720 Jun
EPS$0.43
Beat 104.8%
Q1 200724 Apr
EPS$0.21
Beat 5.0%
Q3 200627 Oct
EPS$0.18
Beat 5.9%
Q2 200626 Jul
EPS$0.16
Beat 14.3%
Q1 200628 Apr
EPS$0.13
Beat 0.0%
Q4 200510 Jan
EPS$0.12
Beat 0.0%
Q2 200527 Sept
EPS$0.11
Beat 0.0%
Q2 20052 Aug
EPS$0.11
Beat 10.0%
Q4 200430 Mar
EPS$0.09
Beat 0.0%
Q4 20046 Jan
EPS$0.10
Beat 0.0%
Q2 200428 Sept
EPS$0.13
Beat 0.0%
Q2 200427 Jul
EPS$0.13
Beat 8.3%
Q1 20041 Apr
EPS$0.12
Beat 0.0%
Q4 200313 Jan
EPS$0.11
Beat 0.0%
Q2 200330 Sept
EPS$0.11
Beat 10.0%
Q2 200321 Jul
EPS$0.11
Beat 10.0%
Q4 200231 Mar
EPS$0.10
Beat 0.0%
Q4 20027 Jan
EPS$0.09
Beat 0.0%
Q3 20028 Oct
EPS$0.08
Beat 0.0%
Q2 200230 Jul
EPS$0.08
Beat 14.3%
Q4 200126 Mar
EPS$0.07
Beat 0.0%
Q4 20018 Jan
EPS$0.07
Beat 0.0%
Q2 200125 Sept
EPS$0.07
Beat 0.0%
Q2 200124 Jul
EPS$0.06
Beat 0.0%
Q4 200027 Mar
EPS$0.06
Beat 0.0%
Q3 20009 Oct
EPS$0.05
Beat 0.0%
Q2 200025 Jul
EPS$0.05
Beat 0.0%
Q1 20004 Apr
EPS$0.05
Beat 0.0%
Q4 199911 Jan
EPS$0.04
Beat 0.0%
Q2 199928 Sept
EPS$0.04
Beat 33.3%
Q4 199830 Mar
EPS$0.05
Beat 25.0%
Q4 199811 Jan
EPS$0.05
Beat 25.0%
Q3 19981 Oct
EPS$0.04
Beat 0.0%

No dividend data available for this stock.

Stock Splits

Split History

13 Aug 2008Stock Split
Ratio2:1
24 Oct 2006Stock Split
Ratio2:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about ICLR

Which members of Congress have traded ICLR?
3 members of Congress have disclosed 13 trades in ICON Public Limited Company (ICLR) under the STOCK Act. The most active traders are Kevin Hern, John James, and Julia Letlow.
When was ICLR most recently disclosed by Congress?
The most recent ICLR disclosure was a sale by Kevin Hern on 14 August 2026.
What is the total disclosed congressional trading volume for ICLR?
Members of Congress have disclosed approximately $322.5K in ICLR purchases and $231.5K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in ICLR?
This ICLR page updates as soon as new STOCK Act disclosures are filed for ICON Public Limited Company. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.